Vaxil Signs Letter of Intent to Acquire a 100% Interest in Short Wave Pharma Inc.

Provided By Globe Newswire

Last update: Oct 14, 2021

Not for distribution by US newswire or in United States

NESS-ZIONA, Israel, Oct. 14, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative biotech company is pleased to announce that the Company has entered into a non-binding letter of intent for the acquisition of 100% of the rights and interests in and to the Short Wave Pharma Inc. (”Shortwave" or "Target") business action (the “Transaction”).